# Perennial Malaria Chemoprevention (PMC) in Cameroon

> **NCT05889052** · — · ACTIVE_NOT_RECRUITING · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 2080 (estimated)

## Conditions studied

- Anemia
- Malaria

## Interventions

- **DRUG:** Sulfadoxine pyrimethamine

## Key facts

- **NCT ID:** NCT05889052
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-19
- **Primary completion:** 2025-09
- **Final completion:** 2025-09
- **Target enrollment:** 2080 (ESTIMATED)
- **Last updated:** 2025-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05889052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05889052, "Perennial Malaria Chemoprevention (PMC) in Cameroon". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05889052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*